Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors

被引：0

作者：

Bromberg, Kenneth D. ^{[1
]}

Lasko, Loren M. ^{[1
]}

Jakob, Clarissa G. ^{[1
]}

Qiu, Wei ^{[1
]}

Montgomery, Debra ^{[1
]}

Digiammarino, Enrico L. ^{[1
]}

Hansen, Todd M. ^{[1
]}

Risi, Roberto M. ^{[1
]}

Frey, Robin R. ^{[1
]}

Manaves, Vlasios ^{[1
]}

Shaw, Bailin ^{[1
]}

Algire, Mikkel ^{[1
]}

Hessler, Paul ^{[1
]}

Lam, Lloyd T. ^{[1
]}

Uziel, Tamar ^{[1
]}

Favire, Emily ^{[1
]}

Ferguson, Debra ^{[1
]}

Buchanan, Fritz G. ^{[1
]}

Martin, Ruth L. ^{[1
]}

Torrent, Maricel ^{[1
]}

Rosenberg, Saul H. ^{[1
]}

Michaelides, Michael R. ^{[1
]}

Lai, Albert ^{[1
]}

机构：

[1] AbbVie Inc, N Chicago, IL USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期

关键词：

D O I：

10.1158/1535-7163.TARG-17-LB-A23

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-A23

引用

页数：2

共 50 条

[31] Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Picaud, Sarah
Fedorov, Oleg
Thanasopoulou, Angeliki
Leonards, Katharina
Jones, Katherine
Meier, Julia
Olzscha, Heidi
Monteiro, Octovia
Martin, Sarah
Philpott, Martin
Tumber, Anthony
Filippakopoulos, Panagis
Yapp, Clarence
Wells, Christopher
Che, Ka Hing
Bannister, Andrew
Robson, Samuel
Kumar, Umesh
Parr, Nigel
Lee, Kevin
Lugo, Dave
Jeffrey, Philip
Taylor, Simon
Vecellio, Matteo L.
Bountra, Chas
Brennan, Paul E.
O'Mahony, Alison
Velichko, Sharlene
Mueller, Susanne
Hay, Duncan
Daniels, Danette L.
Urh, Marjeta
La Thangue, Nicholas B.
Kouzarides, Tony
Prinjha, Rab
Schwaller, Juerg
Knapp, Stefan
CANCER RESEARCH, 2015, 75 (23) : 5106 - 5119
[32] Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
Chen, Zhixiang
Wang, Mi
Wu, Dimin
Bai, Longchuan
Xu, Tianfeng
Metwally, Hoda
Wang, Yu
Mceachern, Donna
Zhao, Lijie
Li, Ruiting
Takyi-Williams, John
Wang, Meilin
Wang, Lu
Li, Qiuxia
Wen, Bo
Sun, Duxin
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) : 5275 - 5304
[33] 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer
Du, Changzheng
Huang, Dandan
Peng, Yifan
Yao, Yunfeng
Zhao, Ying
Yang, Yang
Wang, Haiying
Cao, Linlin
Zhu, Wei-Guo
Gu, Jin
CANCER LETTERS, 2017, 400 : 183 - 193
[34] The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity
Namwanje, Maria
Liu, Longhua
Chan, Michelle
Aaron, Nikki
Kraakman, Michael J.
Qiang, Li
JOURNAL OF ENDOCRINOLOGY, 2019, 240 (02) : 257 - 269
[35] Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases
Michaelides, Michael R.
Kluge, Arthur
Patane, Michael
Van Drie, John H.
Wang, Ce
Hansen, T. Matthew
Risi, Roberto M.
Mantei, Robert
Hertel, Carmen
Karukurichi, Kannan
Nesterov, Alexandre
McElligott, David
de Vries, Peter
Langston, J. William
Cole, Philip A.
Marmorstein, Ronen
Liu, Hong
Lasko, Loren
Bromberg, Kenneth D.
Lai, Albert
Kesicki, Edward A.
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (01): : 28 - 33
[36] CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Hammitzsch, Ariane
Tallant, Cynthia
Fedorov, Oleg
O'Mahony, Alison
Brennan, Paul E.
Hay, Duncan A.
Martinez, Fernando O.
Al-Mossawi, M. Hussein
de Wit, Jelle
Vecellio, Matteo
Wells, Christopher
Wordsworth, Paul
Mueller, Susanne
Knapp, Stefan
Bowness, Paul
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (34) : 10768 - 10773
[37] A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb
Joy, Stephen T.
Henley, Matthew J.
De Salle, Samantha N.
Beyersdorf, Matthew S.
Vock, Isaac W.
Huldin, Allison J. L.
Mapp, Anna K.
Mapp, Anna K. (amapp@umich.edu), 1600, American Chemical Society (143): : 15056 - 15062
[38] NEO2734, a novel dual BET and P300/CBP bromodomain inhibitor, is more active in NUT midline carcinoma than single agent BET or P300/CBP inhibitors
Tian, Tian
Cosin, Marc
Giles, Francis
Brana, Irene
Garralda, Elena
Peiro, Sandra
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
[39] An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells
Gu, Meng-Li
Wang, Ya-Mei
Zhou, Xin-Xin
Yao, Hang-Ping
Zheng, Song
Xiang, Zun
Ji, Feng
ONCOLOGY REPORTS, 2016, 36 (05) : 2763 - 2770
[40] Probing p300/CBP Associated Factor (PCAF)-Dependent Pathways with a Small Molecule Inhibitor
Modak, Rahul
Basha, Jeelan
Bharathy, Narendra
Maity, Koustav
Mizar, Pushpak
Bhat, Akshay V.
Vasudevan, Madavan
Rao, Vinay Kumar
Kok, Wai Kay
Natesh, Nagashayana
Taneja, Reshma
Kundu, Tapas K.
ACS CHEMICAL BIOLOGY, 2013, 8 (06) : 1311 - 1323

← 1 2 3 4 5 →